Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Know Labs (KNW)

Know Labs Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:KNW
DateTimeSourceHeadlineSymbolCompany
05/06/202414:00Business WireKnow Labs Joins the Industrial Participant Program of the Wyss Institute for Biologically Inspired Engineering at Harvard UniversityAMEX:KNWKnow Labs Inc
03/06/202419:11Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:KNWKnow Labs Inc
29/05/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:KNWKnow Labs Inc
16/05/202414:00Business WireKnow Labs Appoints Chris Somogyi as President, InternationalAMEX:KNWKnow Labs Inc
15/05/202421:15Business WireKnow Labs, Inc. Reports Second Quarter FY 2024 ResultsAMEX:KNWKnow Labs Inc
09/05/202414:00Business WireKnow Labs to Present Clinical Research at the 2024 American Association of Clinical Endocrinology Annual MeetingAMEX:KNWKnow Labs Inc
08/05/202414:00Business WireKnow Labs, Inc. to Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024AMEX:KNWKnow Labs Inc
05/04/202414:00Business WireKnow Labs to Present Clinical Research at the 2024 American Physiology SummitAMEX:KNWKnow Labs Inc
06/03/202421:15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]AMEX:KNWKnow Labs Inc
06/03/202421:10Edgar (US Regulatory)Form 8-K - Current reportAMEX:KNWKnow Labs Inc
06/03/202414:00Business WireKnow Labs’ Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research StudyAMEX:KNWKnow Labs Inc
29/02/202421:17Edgar (US Regulatory)Form 8-K - Current reportAMEX:KNWKnow Labs Inc
29/02/202421:15Business WireKnow Labs Secures U.S. $12 Million Funding for Company’s Further Execution on Its Clinical Research and Development InitiativesAMEX:KNWKnow Labs Inc
27/02/202416:44Business WireKnow Labs Announces the KnowU™, its Wearable Non-Invasive Continuous Glucose MonitorAMEX:KNWKnow Labs Inc
27/02/202414:03Edgar (US Regulatory)Form 8-K - Current reportAMEX:KNWKnow Labs Inc
27/02/202414:00Business WireKnow Labs Announces the KnowU™, its Wearable Non-Invasive Continuous Glucose MonitorAMEX:KNWKnow Labs Inc
14/02/202421:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:KNWKnow Labs Inc
14/02/202421:15Edgar (US Regulatory)Form 8-K - Current reportAMEX:KNWKnow Labs Inc
14/02/202421:15Business WireKnow Labs, Inc. Reports First Quarter FY2024 ResultsAMEX:KNWKnow Labs Inc
09/02/202421:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:KNWKnow Labs Inc
09/02/202421:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:KNWKnow Labs Inc
09/02/202421:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:KNWKnow Labs Inc
09/02/202421:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:KNWKnow Labs Inc
09/02/202421:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:KNWKnow Labs Inc
09/02/202421:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:KNWKnow Labs Inc
07/02/202414:00Business WireKnow Labs, Inc. to Host Review of First Quarter Fiscal Year 2024 Results on February 14, 2024AMEX:KNWKnow Labs Inc
23/01/202414:00Business WireKnow Labs to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)AMEX:KNWKnow Labs Inc
12/01/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:KNWKnow Labs Inc
05/01/202421:16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]AMEX:KNWKnow Labs Inc
22/12/202321:15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:KNWKnow Labs Inc
 Showing the most relevant articles for your search:AMEX:KNW